Reconceptualizing podocyte damage in Fabry disease: new findings identify α-synuclein as a putative therapeutic

Dominique P Germain1

  • 1Division of Medical Genetics, University of Versailles-St Quentin en Yvelines, Montigny, France; French Reference Centre for Fabry Disease, Division of Medical Genetics, AP-HP Paris Saclay University, Garches, France.

Kidney International
|September 15, 2023
PubMed
Abstract

No abstract available in PubMed .